Publications by authors named "Prafull Mistry"

Claim this Profile
A
A randomized, phase II study of sequential belimumab and rituximab in primary Sjögren's syndrome.
Xavier Mariette, Francesca Barone, Chiara Baldini, Hendrika Bootsma, Kenneth L Clark, Prafull Mistry

JCI Insight· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantifying disease activity in rheumatoid arthritis with the TSPO PET ligand F-GE-180 and comparison with F-FDG and DCE-MRI.
Marius de Groot, Neel Patel, Roido Manavaki, Robert L Janiczek, Mats Bergstrom, Prafull Mistry

EJNMMI Res· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Safety and Efficacy of Belimumab in Patients With Systemic Lupus Erythematosus: A Continuation of a Seventy-Six-Week Phase III Parent Study in the United States.
Richard A Furie, Daniel J Wallace, Cynthia Aranow, James Fettiplace, Barbara Wilson, Prafull Mistry

Arthritis Rheumatol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Study to Investigate the Efficacy and Safety of an Anti-Interleukin-18 Monoclonal Antibody in the Treatment of Type 2 Diabetes Mellitus.
Elizabeth A McKie, Juliet L Reid, Prafull C Mistry, Stephen L DeWall, Lee Abberley

PLoS One· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic and Pharmacodynamic Characterisation of an Anti-Mouse TNF Receptor 1 Domain Antibody Formatted for In Vivo Half-Life Extension.
Laura J Goodall, Milan Ovecka, Daniel Rycroft, Sarah L Friel, Andrew Sanderson, Prafull Mistry

PLoS One· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First administration of the Fc-attenuated anti-β amyloid antibody GSK933776 to patients with mild Alzheimer's disease: a randomized, placebo-controlled study.
Niels Andreasen, Monica Simeoni, Henrik Ostlund, Pia I Lisjo, Tormod Fladby, Prafull C Mistry

PLoS One· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, pharmacokinetics, and pharmacodynamics of single-dose antiinterleukin- 18 mAb GSK1070806 in healthy and obese subjects.
Prafull Mistry, Juliet Reid, Isabelle Pouliquen, Simon McHugh, Lee Abberley

Int J Clin Pharmacol Ther· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of β-amyloid by a single dose of GSK933776 in patients with mild Alzheimer's disease: a phase I study.
Thomas Leyhe, Niels Andreasen, Monica Simeoni, Arno Reich, Christine Af von Arnim, Prafull Mistry

Alzheimers Res Ther· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of antidepressant properties of the p38 MAP kinase inhibitor losmapimod (GW856553) in Major Depressive Disorder: Results from two randomised, placebo-controlled, double-blind, multicentre studies using a Bayesian approach.
Amir Inamdar, Emilio Merlo-Pich, Michelle Gee, Clare Makumi, Prafull Mistry

J Psychopharmacol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective blockade of tumor necrosis factor receptor I inhibits proinflammatory cytokine and chemokine production in human rheumatoid arthritis synovial membrane cell cultures.
Emily M Schmidt, Marie Davies, Prafull Mistry, Patricia Green, Grey Giddins

Arthritis Rheum· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of the analgesic effect of remifentanil using three pain models in healthy Korean volunteers: a randomized, controlled study.
Tae-Eun Kim, Kyu-Pyo Kim, Donghoon Shin, Yong-Ju Chung, Jeffrey Price, Prafull Mistry

Basic Clin Pharmacol Toxicol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-center randomized proof-of-concept clinical trial applying [¹⁸F]FDG-PET for evaluation of metabolic therapy with rosiglitazone XR in mild to moderate Alzheimer's disease.
Sofia Tzimopoulou, Vincent J Cunningham, Thomas E Nichols, Graham Searle, Nick P Bird, Prafull Mistry

J Alzheimers Dis· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged pharmacodynamic effects of S-0139, an intravenously administered endothelin A (ET) antagonist, in the human forearm blood flow model.
Martin W Lunnon, Sharon M L Wallace, Joanne E Palmer, Andrew Francis-Lang, Bart E Laurijssens, Prafull Mistry

Br J Clin Pharmacol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis